prednisolone has been researched along with Agnogenic Myeloid Metaplasia in 43 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Excerpt | Relevance | Reference |
---|---|---|
"Low-dose thalidomide and prednisone alone or combined are effective therapies in some persons with primary myelofibrosis (PMF) and anemia with or with RBC transfusion dependence." | 9.27 | Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response. ( Fang, L; Hu, N; Huang, G; Li, B; Luo, X; Pan, L; Peter Gale, R; Qin, T; Qu, S; Xiao, Z; Xu, Z; Zhang, H; Zhang, P; Zhang, Y, 2018) |
"A 73-year-old man with primary myelofibrosis (PMF) was being treated with hydroxyurea, which was changed to ruxolitinib treatment because of worsening constitutional symptoms." | 8.98 | Fatal Disseminated Tuberculosis during Treatment with Ruxolitinib Plus Prednisolone in a Patient with Primary Myelofibrosis: A Case Report and Review of the Literature. ( Ikeda, M; Kiyasu, J; Ogawa, Y; Shiratsuchi, M; Tsuda, M; Tsukamoto, Y; Yufu, Y, 2018) |
"Primary myelofibrosis was diagnosed in a 43-year-old female in 1991, who gradually became transfusion dependent." | 5.29 | [Primary myelofibrosis with positive coombs' test responding to prednisolone]. ( Okuda, T; Yoshida, Y; Yumoto, Y, 1996) |
"Low-dose thalidomide and prednisone alone or combined are effective therapies in some persons with primary myelofibrosis (PMF) and anemia with or with RBC transfusion dependence." | 5.27 | Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response. ( Fang, L; Hu, N; Huang, G; Li, B; Luo, X; Pan, L; Peter Gale, R; Qin, T; Qu, S; Xiao, Z; Xu, Z; Zhang, H; Zhang, P; Zhang, Y, 2018) |
"A 73-year-old man with primary myelofibrosis (PMF) was being treated with hydroxyurea, which was changed to ruxolitinib treatment because of worsening constitutional symptoms." | 4.98 | Fatal Disseminated Tuberculosis during Treatment with Ruxolitinib Plus Prednisolone in a Patient with Primary Myelofibrosis: A Case Report and Review of the Literature. ( Ikeda, M; Kiyasu, J; Ogawa, Y; Shiratsuchi, M; Tsuda, M; Tsukamoto, Y; Yufu, Y, 2018) |
"Prednisolone was added if there was no response after 3 months in cohort 1 and based on up-front randomization in cohort 2 if there was no response at 3 or 6 months." | 2.84 | Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis. ( Benner, A; Blau, IW; Döhner, H; Döhner, K; Gattermann, N; Grießhammer, M; Hebart, H; Heidel, FH; Hochhaus, A; Jost, E; Kreipe, H; Platzbecker, U; Reiter, A; Schafhausen, P; Schlenk, RF; Stegelmann, F; Teleanu, V; Verbeek, W; Waller, C; Werner, M, 2017) |
"We report two additional patients with acute myeloid leukemia (AML) and a translocation between chromosomes 7 and 11: t(7;11)(p15;p15)." | 2.38 | Two additional cases of acute myeloid leukemia with t(7;11)(p15;p15) having low neutrophil alkaline phosphatase scores. ( Fujimura, T; Iwabuchi, A; Kawakubo, K; Kodama, A; Ohyashiki, JH; Ohyashiki, K; Toyama, K, 1993) |
"Oral prednisolone was initiated; it gradually improved his anemia and rendered the patient free of transfusion." | 1.37 | Myelofibrosis successfully treated with prednisolone in a patient with pachydermoperiostosis. ( Hara, T; Hirose, Y; Kanemura, N; Kasahara, S; Moriwaki, H; Ninomiya, S; Ogawa, Y; Seishima, M; Tsurumi, H, 2011) |
"Due to secondary myelofibrosis accompanied by Sjögren syndrome, she was started on prednisolone (PSL) and recovered completely from the anemia and thrombocytopenia." | 1.34 | [Successful treatment with prednisolone for autoimmune myelofibrosis accompanied with Sjögren syndrome]. ( Hattori, N; Maeda, T; Nakamaki, T; Nakashima, H; Tomoyasu, S; Usui, T; Yanagisawa, K, 2007) |
"Myelofibrosis with myeloid metaplasia is defined as a myeloproliferative disorder characterized by leukoerythroblastosis, tear drop erythrocytes, extramedullary hematopoesis and varying degree of myelofibrosis." | 1.33 | Juvenile rheumatoid arthritis with myelofibrosis with myeloid metaplasia. ( Gulati, S; Jain, V; Kabra, M; Kalra, V; Maheshwari, A, 2005) |
"Prednisolone was tapered off over the next 3 weeks." | 1.31 | Myelodysplastic syndrome complicated by autoimmune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil. ( Chao, TC; Chen, PM; Chiou, TJ; Hsiao, LT; Lin, JT; Liu, JH; Tai, CJ; Wang, WS; Yang, MH; Yen, CC, 2002) |
"B-cell chronic lymphocytic leukemia (B-CLL) associated with bone marrow fibrosis is described." | 1.29 | Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis. ( Hyodo, H; Kimura, A; Kuramoto, A; Nakata, Y, 1993) |
"This case was considered to be an acute myelofibrosis developed from myelodysplastic syndrome and worth to reporting with a review of literature, because drastic combination chemotherapy was extremely effective." | 1.29 | [Successful treatment with combination chemotherapy of BHAC-AMP in a case of acute myelofibrosis developed from myelodysplastic syndrome with multiple chromosomal aberrations]. ( Fujita, H; Hirayama, M; Kohgo, Y; Kura, T; Mogi, Y; Nakaya, R; Niitsu, Y; Tsuji, N; Watanabe, N, 1993) |
"Primary myelofibrosis was diagnosed in a 43-year-old female in 1991, who gradually became transfusion dependent." | 1.29 | [Primary myelofibrosis with positive coombs' test responding to prednisolone]. ( Okuda, T; Yoshida, Y; Yumoto, Y, 1996) |
"A 64 year-old female patient of idiopathic myelofibrosis (IMF), who had had rapidly progressing massive splenomegaly and severe pancytopenia refractory to blood transfusion, was treated with PSL 0." | 1.28 | [Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone]. ( Ikeda, Y; Kubo, A; Masuda, Y; Michikawa, N; Ogawa, T; Tanosaki, R; Uchida, H, 1992) |
"The coexistence of myelofibrosis and pancytopenia in patients with systemic lupus erythematosus has been reported, but their possible causal relationship remains unresolved." | 1.27 | Myelofibrosis and pancytopenia in systemic lupus erythematosus. ( Ahmad, MA; al Fadel Saleh, M; al Gindan, YM; al Sohaibani, MO; el Mouzan, MI, 1988) |
"A bone marrow biopsy disclosed severe myelofibrosis and many megakaryocytes, which appeared morphologically normal." | 1.27 | A distinct subtype of idiopathic myelofibrosis with bone marrow features mimicking hairy cell leukemia: evidence of an autoimmune pathogenesis. ( Hasselbalch, H; Jans, H; Nielsen, PL, 1987) |
"All patients except one with aplastic anaemia responded with an increase in reticulocytes, haematocrit, red blood cell mass, and blood neutrophils and platelets." | 1.26 | Aetiocholanolone and prednisolone therapy in patients with severe bone-marrow failure. ( Besa, EC; Dale, DC; Gardner, FH; Wolff, SM, 1977) |
"Biopsy provided evidence for myelofibrosis with extramedullary erythropoiesis." | 1.26 | [Transitory myelofibrosis in a case of diaphyseal dysplasia (Camurati-Engelmann's disease) (author's transl)]. ( Bechrakis, G; Emons, D; Födisch, HJ; Hussel, D, 1978) |
"Although splenomegaly was of only moderate degree, severe anemia and thrombocytopenia supervened." | 1.26 | Myelofibrosis and rapid thrombocytolysis. A case report. ( Bergström, AL; Kutti, J; Ridell, B, 1977) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (32.56) | 18.7374 |
1990's | 9 (20.93) | 18.2507 |
2000's | 8 (18.60) | 29.6817 |
2010's | 12 (27.91) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ohkawara, H | 1 |
Furukawa, M | 1 |
Ikeda, K | 1 |
Shichishima-Nakamura, A | 1 |
Fukatsu, M | 1 |
Sano, T | 1 |
Ueda, K | 1 |
Kimura, S | 1 |
Kanai, R | 1 |
Oka, Y | 1 |
Murakami, F | 1 |
Suzuki, O | 1 |
Hashimoto, Y | 1 |
Ogawa, K | 1 |
Ikezoe, T | 1 |
Tsukamoto, Y | 1 |
Kiyasu, J | 1 |
Tsuda, M | 1 |
Ikeda, M | 1 |
Shiratsuchi, M | 2 |
Ogawa, Y | 2 |
Yufu, Y | 1 |
Luo, X | 1 |
Xu, Z | 1 |
Li, B | 1 |
Qin, T | 1 |
Zhang, P | 1 |
Zhang, H | 1 |
Fang, L | 1 |
Pan, L | 1 |
Hu, N | 1 |
Qu, S | 1 |
Zhang, Y | 1 |
Huang, G | 1 |
Peter Gale, R | 1 |
Xiao, Z | 1 |
Hideki, M | 1 |
Tetsurou, T | 1 |
Sakae, F | 1 |
Kensei, K | 1 |
Makoto, O | 1 |
Toshinobu, K | 1 |
Shimoda, K | 1 |
Takenaka, K | 1 |
Kitanaka, A | 1 |
Akashi, K | 1 |
Takahashi, T | 1 |
Sekiguchi, Y | 1 |
Shirane, S | 1 |
Shimada, A | 1 |
Ichikawa, K | 1 |
Wakabayashi, M | 1 |
Sugimoto, K | 1 |
Tomita, S | 1 |
Izumi, H | 1 |
Nakamura, N | 1 |
Sawada, T | 1 |
Ohta, Y | 1 |
Komatsu, N | 1 |
Noguchi, M | 1 |
Schlenk, RF | 1 |
Stegelmann, F | 1 |
Reiter, A | 1 |
Jost, E | 1 |
Gattermann, N | 1 |
Hebart, H | 1 |
Waller, C | 1 |
Hochhaus, A | 1 |
Platzbecker, U | 1 |
Schafhausen, P | 1 |
Blau, IW | 1 |
Verbeek, W | 1 |
Heidel, FH | 1 |
Werner, M | 1 |
Kreipe, H | 1 |
Teleanu, V | 1 |
Benner, A | 1 |
Döhner, H | 1 |
Grießhammer, M | 1 |
Döhner, K | 1 |
Weinkove, R | 1 |
Reilly, JT | 1 |
McMullin, MF | 1 |
Curtin, NJ | 1 |
Radia, D | 1 |
Harrison, CN | 1 |
Mesa, RA | 1 |
Pardanani, AD | 1 |
Hussein, K | 1 |
Wu, W | 1 |
Schwager, S | 1 |
Litzow, MR | 1 |
Hogan, WJ | 1 |
Tefferi, A | 1 |
Sarkar, RN | 1 |
Banerjee, S | 1 |
Dey, S | 1 |
Saha, A | 1 |
Bhattacharjee, P | 1 |
Banerjee, TK | 1 |
Sinha, PK | 1 |
Chakraborty, A | 1 |
Takai, K | 1 |
Nikkuni, K | 1 |
Shibuya, H | 1 |
Hashidate, H | 1 |
Hattori, Y | 1 |
Miyakawa, Y | 1 |
Yokoyama, K | 1 |
Yamada, T | 1 |
Du, W | 1 |
Jinzaki, M | 1 |
Shinmoto, H | 1 |
Okamoto, S | 1 |
Ninomiya, S | 1 |
Hara, T | 1 |
Tsurumi, H | 1 |
Kanemura, N | 1 |
Kasahara, S | 1 |
Seishima, M | 1 |
Hirose, Y | 1 |
Moriwaki, H | 1 |
Lin, JT | 1 |
Wang, WS | 1 |
Yen, CC | 1 |
Chiou, TJ | 1 |
Liu, JH | 1 |
Hsiao, LT | 1 |
Yang, MH | 1 |
Chao, TC | 1 |
Tai, CJ | 1 |
Chen, PM | 1 |
PENGELLY, CD | 1 |
ROTHERMUNDT, A | 1 |
KIMBER, RJ | 1 |
LANDER, H | 1 |
ROBSON, HN | 1 |
Jain, V | 1 |
Maheshwari, A | 1 |
Gulati, S | 1 |
Kabra, M | 1 |
Kalra, V | 1 |
Hagihara, M | 1 |
Watanabe, S | 1 |
Suyama, T | 1 |
Sato, K | 1 |
Ito, A | 1 |
Umeda, M | 1 |
Koike, T | 1 |
Naruse, S | 1 |
Fujita, N | 1 |
Hattori, N | 1 |
Nakashima, H | 1 |
Usui, T | 1 |
Maeda, T | 1 |
Yanagisawa, K | 1 |
Nakamaki, T | 1 |
Tomoyasu, S | 1 |
Kueh, YK | 1 |
Oon, CJ | 1 |
Kimura, A | 1 |
Hyodo, H | 1 |
Nakata, Y | 1 |
Kuramoto, A | 1 |
Fujimura, T | 1 |
Ohyashiki, K | 1 |
Ohyashiki, JH | 1 |
Kawakubo, K | 1 |
Iwabuchi, A | 1 |
Kodama, A | 1 |
Toyama, K | 1 |
Tsuji, N | 1 |
Mogi, Y | 1 |
Nakaya, R | 1 |
Kura, T | 1 |
Fujita, H | 1 |
Hirayama, M | 1 |
Watanabe, N | 1 |
Kohgo, Y | 1 |
Niitsu, Y | 1 |
Imai, Y | 1 |
Akiyama, N | 1 |
Hanazono, Y | 1 |
Inamori, K | 1 |
Mitani, K | 1 |
Hirai, H | 1 |
Nagai, R | 1 |
Yazaki, Y | 1 |
Yumoto, Y | 1 |
Okuda, T | 1 |
Yoshida, Y | 1 |
Agarwal, BR | 1 |
Bhalla, K | 1 |
Dalvi, R | 1 |
Currimbhoy, ZE | 1 |
Mehta, KP | 1 |
Abe, Y | 1 |
Ohshima, K | 1 |
Honda, K | 1 |
Nishimura, J | 1 |
Nawata, H | 1 |
Muta, K | 1 |
Besa, EC | 1 |
Wolff, SM | 1 |
Dale, DC | 1 |
Gardner, FH | 1 |
Emons, D | 1 |
Hussel, D | 1 |
Bechrakis, G | 1 |
Födisch, HJ | 1 |
Kutti, J | 1 |
Bergström, AL | 1 |
Ridell, B | 1 |
Tanosaki, R | 1 |
Uchida, H | 1 |
Masuda, Y | 1 |
Michikawa, N | 1 |
Ogawa, T | 1 |
Kubo, A | 1 |
Ikeda, Y | 1 |
Narayanan, MN | 1 |
Benaim, ME | 1 |
Geary, CG | 1 |
Harrison, CJ | 1 |
Watts, EJ | 1 |
Majer, RV | 1 |
Green, PJ | 1 |
Mavor, WO | 1 |
el Mouzan, MI | 1 |
Ahmad, MA | 1 |
al Fadel Saleh, M | 1 |
al Sohaibani, MO | 1 |
al Gindan, YM | 1 |
Patterson, KG | 1 |
Treleaven, JG | 1 |
Zuiable, A | 1 |
Hasselbalch, H | 1 |
Jans, H | 1 |
Nielsen, PL | 1 |
Pyörälä, K | 1 |
Suhonen, O | 1 |
Pentikäinan, P | 1 |
Demidova, AV | 1 |
Barkhan, P | 1 |
Hauswaldt, C | 1 |
Hunseein, W | 1 |
Kaboth, U | 1 |
Lattermann, W | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Multi-Center Phase II Study With Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage[NCT00949364] | Phase 2 | 103 participants (Actual) | Interventional | 2009-12-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 reviews available for prednisolone and Agnogenic Myeloid Metaplasia
Article | Year |
---|---|
Fatal Disseminated Tuberculosis during Treatment with Ruxolitinib Plus Prednisolone in a Patient with Primary Myelofibrosis: A Case Report and Review of the Literature.
Topics: Aged; Fatal Outcome; Humans; Hydroxyurea; Male; Prednisolone; Primary Myelofibrosis; Pyrazoles; Tube | 2018 |
[Clinical aspects of primary myelofibrosis in Japan].
Topics: Blood Cell Count; Danazol; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Japan; Meth | 2014 |
Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bone Marrow; Bone M | 2015 |
Two additional cases of acute myeloid leukemia with t(7;11)(p15;p15) having low neutrophil alkaline phosphatase scores.
Topics: Acute Disease; Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bone Mar | 1993 |
5 trials available for prednisolone and Agnogenic Myeloid Metaplasia
Article | Year |
---|---|
Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response.
Topics: Adult; Aged; Anemia; Danazol; Female; Humans; Male; Middle Aged; Prednisolone; Primary Myelofibrosis | 2018 |
Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis.
Topics: Aged; Aged, 80 and over; Alleles; Biomarkers; Chromosome Banding; Female; Humans; Immunologic Factor | 2017 |
Low-dose thalidomide in myelofibrosis.
Topics: Aged; Aged, 80 and over; Blood Transfusion; Female; Humans; Immunosuppressive Agents; Male; Middle A | 2008 |
Phase1/-2 study of Pomalidomide in myelofibrosis.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Anti-Inflammatory Agents; Female; Humans; Immunosuppressive | 2010 |
Prospective study of combination therapy with low-dose thalidomide plus prednisolone ameliorating cytopenia in primary myelofibrosis.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Fe | 2011 |
34 other studies available for prednisolone and Agnogenic Myeloid Metaplasia
Article | Year |
---|---|
Steroid-resistant autoimmune myelofibrosis in a patient with autoimmune hepatitis and Evans syndrome complicated with increased expression of TGF-β in the bone marrow: a case report.
Topics: Anemia, Hemolytic, Autoimmune; Bone Marrow; Drug Resistance; Female; Hepatitis, Autoimmune; Humans; | 2017 |
Idiopathic myelofibrosis and pyoderma gangrenosum involving a mutation of Janus kinase 2 (JAK2V617F), showing poor prognosis.
Topics: Aged; Anti-Inflammatory Agents; Colitis, Ulcerative; Enterococcus; Fatal Outcome; Humans; Janus Kina | 2013 |
Autoimmune myelofibrosis accompanied by Sjögren's syndrome in a 47, XXX/46, XX mosaic woman.
Topics: Adult; Chromosomes, Human, X; Female; Follow-Up Studies; Genetic Testing; Glucocorticoids; Humans; P | 2014 |
Haematological presentation of systemic lupus erythematosus.
Topics: Anemia, Hemolytic; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Pancyt | 2009 |
[Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly].
Topics: Ascites; Cyclosporine; Diagnosis, Differential; Fatal Outcome; Female; Fever; Hepatomegaly; Humans; | 2010 |
Myelofibrosis successfully treated with prednisolone in a patient with pachydermoperiostosis.
Topics: Anemia; Bone Marrow; DNA Mutational Analysis; Humans; Janus Kinase 2; Male; Osteoarthropathy, Primar | 2011 |
Myelodysplastic syndrome complicated by autoimmune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Anemia, Refractory; Antineoplastic Combined Chemotherapy Proto | 2002 |
STIMULATION OF RED-CELL PRODUCTION IN MYELOFIBROSIS WITH PREDNISOLONE.
Topics: Blood Transfusion; Erythropoiesis; Humans; Prednisolone; Primary Myelofibrosis | 1964 |
[MASSIVE CELL INFILTRATION OF THE PULMONARY PARENCHYMA IN ALEUKEMIC CHRONIC MYELOSIS].
Topics: Humans; Leukemia; Leukemia, Myeloid; Lung; Lung Diseases; Myeloproliferative Disorders; Pathology; P | 1964 |
THE SEQUESTRATION OF NEM-TREATED RED CELLS IN NORMAL AND ABNORMAL SUBJECTS: A TEST OF SPLENIC UPTAKE FUNCTION.
Topics: Anemia; Anemia, Hemolytic; Erythrocytes; Ethylmaleimide; Hodgkin Disease; Humans; Liver; Liver Cirrh | 1965 |
Juvenile rheumatoid arthritis with myelofibrosis with myeloid metaplasia.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; Child; Drug Therapy, Combinatio | 2005 |
[Epstein-Barr virus related B-cell lymphoproliferative disorder complicated with bone marrow fibrosis, which was successfully treated with 2 courses of CHOP regimen].
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; B-Lymphocytes; Cyclophosphamide; D | 2005 |
[A case of dermatomyositis associated with chronic idiopathic myelofibrosis].
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Chronic Disease; Dermatomyositis; Drug Therapy, Combin | 2006 |
[Successful treatment with prednisolone for autoimmune myelofibrosis accompanied with Sjögren syndrome].
Topics: Aged; Autoimmune Diseases; Female; Humans; Prednisolone; Primary Myelofibrosis; Sjogren's Syndrome | 2007 |
Acute myelofibrosis (myelosclerosis) presenting as a case of severe thrombocytopenic purpura.
Topics: Acute Disease; Adult; Female; Humans; Prednisolone; Primary Myelofibrosis; Purpura, Thrombocytopenic | 1982 |
Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Division; Cells, Cul | 1993 |
[Successful treatment with combination chemotherapy of BHAC-AMP in a case of acute myelofibrosis developed from myelodysplastic syndrome with multiple chromosomal aberrations].
Topics: Aclarubicin; Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosome | 1993 |
[Successful treatment of splenomegaly and anemia by VP therapy in idiopathic myelofibrosis complicated with acromegaly: a case report].
Topics: Acromegaly; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Prednisolone | 1995 |
[Primary myelofibrosis with positive coombs' test responding to prednisolone].
Topics: Adult; Coombs Test; Female; Glucocorticoids; Humans; Prednisolone; Primary Myelofibrosis | 1996 |
Myelofibrosis secondary to SLE and its reversal on steroid therapy.
Topics: Biopsy, Needle; Bone Marrow; Child; Female; Follow-Up Studies; Glucocorticoids; Humans; Lupus Erythe | 1995 |
Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Doxorubi | 2001 |
Aetiocholanolone and prednisolone therapy in patients with severe bone-marrow failure.
Topics: Adult; Aged; Anemia, Aplastic; Blood Cell Count; Cell Survival; Drug Combinations; Etiocholanolone; | 1977 |
[Transitory myelofibrosis in a case of diaphyseal dysplasia (Camurati-Engelmann's disease) (author's transl)].
Topics: Bone Diseases, Developmental; Camurati-Engelmann Syndrome; Child, Preschool; Humans; Male; Prednisol | 1978 |
Myelofibrosis and rapid thrombocytolysis. A case report.
Topics: Aged; Blood Cell Count; Blood Platelets; Bone Marrow; Cell Survival; Female; Hematopoiesis; Humans; | 1977 |
[Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone].
Topics: Bone Marrow; Female; Hematopoiesis; Humans; Middle Aged; Prednisolone; Primary Myelofibrosis | 1992 |
Hyperfibrotic myelodysplasia.
Topics: Blood Cell Count; Female; Humans; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Primary Myel | 1991 |
Hyperfibrotic myelodysplasia: a report of three cases showing haematological remission following treatment with prednisolone.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Primary Mye | 1991 |
Myelofibrosis and pancytopenia in systemic lupus erythematosus.
Topics: Adolescent; Female; Humans; Lupus Erythematosus, Systemic; Pancytopenia; Prednisolone; Primary Myelo | 1988 |
Marrow fibrosis in myeloma: improvement by alkylating agent therapy.
Topics: Alkylating Agents; Biopsy; Bone Marrow; Humans; Melphalan; Middle Aged; Multiple Myeloma; Prednisolo | 1988 |
A distinct subtype of idiopathic myelofibrosis with bone marrow features mimicking hairy cell leukemia: evidence of an autoimmune pathogenesis.
Topics: Adult; Autoimmune Diseases; Bone Marrow; Bone Marrow Cells; Diagnosis, Differential; Female; Humans; | 1987 |
Steroid therapy and hyperosmolar non-ketotic coma.
Topics: Adult; Diabetic Coma; Female; Glucocorticoids; Humans; Hydrocortisone; Lupus Erythematosus, Systemic | 1968 |
[Primary myelofibrosis (osteomyelosclerosis). Current views on the pathogenesis, clinical course, diagnosis and therapy].
Topics: Anabolic Agents; Antineoplastic Agents; Blood Transfusion; Humans; Methyltestosterone; Prednisolone; | 1974 |
Blood and neoplastic diseases. Thrombocytopenia.
Topics: Aminocaproates; Anemia, Aplastic; Blood Transfusion; Bone Marrow Diseases; Female; Humans; Leukemia; | 1974 |
[Animal experimental production of bone marrow fibroses using repeated injections of foreign protein and their medicamentous influencing through azathioprine and prednisolone].
Topics: Animals; Azathioprine; Ovalbumin; Prednisolone; Primary Myelofibrosis; Rabbits | 1969 |